ACP3 and cancer: Taken together, we believe ACPP–drug conjugates can foster the clinical translation of targeted anti-cancer drugs as pre-clinical tool molecules for evaluating ADC drug payloads in immune-competent murine models and for continued clinical development as receptor-independent actively targeted therapeutic delivery vehicles.